Furthermore, the combined model II (RBP4/HOMA-IR/diabetes duration/Hs-CRP/HbA1c) did not improved the ability of model I to diagnose VTDR (AUC of the combined model 0.94; 95% CI: 0.86–0.96; P>0.05). This evidence concerns the gene CRP and diabetes mellitus.